Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Tyrosine-protein kinase Mer | ||
Ligand | BDBM50055496 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1451349 (CHEMBL3363368) | ||
IC50 | 2.7±n/a nM | ||
Citation | Zhang, W; DeRyckere, D; Hunter, D; Liu, J; Stashko, MA; Minson, KA; Cummings, CT; Lee, M; Glaros, TG; Newton, DL; Sather, S; Zhang, D; Kireev, D; Janzen, WP; Earp, HS; Graham, DK; Frye, SV; Wang, X UNC2025, a potent and orally bioavailable MER/FLT3 dual inhibitor. J Med Chem57:7031-41 (2014) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Tyrosine-protein kinase Mer | |||
Name: | Tyrosine-protein kinase Mer | ||
Synonyms: | MER | MER intracellular domain/EGFR extracellular domain chimera | MERTK | MERTK_HUMAN | Proto-oncogene c-Mer | Proto-oncogene tyrosine-protein kinase MER | Receptor tyrosine kinase MerTK | Tyrosine-protein kinase Mer | ||
Type: | PROTEIN | ||
Mol. Mass.: | 110234.77 | ||
Organism: | Homo sapiens (Human) | ||
Description: | ChEMBL_1498723 | ||
Residue: | 999 | ||
Sequence: |
| ||
BDBM50055496 | |||
n/a | |||
Name | BDBM50055496 | ||
Synonyms: | CHEMBL3326006 | ||
Type | Small organic molecule | ||
Emp. Form. | C28H40N6O | ||
Mol. Mass. | 476.6568 | ||
SMILES | CCCCNc1ncc2c(cn([C@H]3CC[C@H](O)CC3)c2n1)-c1ccc(CN2CCN(C)CC2)cc1 |r,wU:12.11,wD:15.15,(14.5,-10.38,;14.49,-11.92,;15.83,-12.69,;17.16,-11.92,;18.49,-12.69,;19.83,-11.92,;19.83,-10.38,;21.16,-9.61,;22.49,-10.37,;23.97,-9.89,;24.88,-11.15,;23.97,-12.4,;24.44,-13.87,;25.95,-14.19,;26.42,-15.66,;25.39,-16.8,;25.86,-18.27,;23.88,-16.47,;23.41,-15.02,;22.49,-11.92,;21.16,-12.69,;24.45,-8.43,;25.96,-8.11,;26.43,-6.65,;25.41,-5.5,;25.89,-4.03,;27.4,-3.74,;28.41,-4.9,;29.91,-4.6,;30.41,-3.14,;31.92,-2.84,;29.4,-1.99,;27.88,-2.28,;23.9,-5.82,;23.42,-7.29,)| | ||
Structure |